Coronavirus mutations in New York, California cause concern Science In – depth science and technology reporting DW

Since health authorities began to sequence COVID-19 positive cases more closely – that is, by genetically examining test results – they have also found more and more mutations.

Most of these mutations are insignificant. But there are several options that researchers and officials are concerned about, in part because they are more contagious and because existing vaccines may be less effective in protecting against them.

A checkpoint on the Czech-German border

No more freedom of movement. Some countries are trying to stop the spread of mutations by closing borders.

In addition to the variants identified in the United Kingdom, South Africa and Brazil, there are two other variants of concern in the United States, which appear to have evolved there.

Fast spread

In November, researchers first noticed a mutation in New York called B.1.526. Since then, this variant has spread rapidly in the metropolis and throughout the state. By mid-February, it was detected in 12% of all New York samples that were sequenced by genes.

This variant has also appeared in other countries, such as Denmark.

A woman wearing a face mask is jogging in the background of the Golden Gate Bridge

The California variant, CAL.20, is thought to be more contagious than the original virus, but not as dangerous as the British version.

The so-called California variant, first detected in July 2020, also spread rapidly. Meanwhile, the two similar types, B.1.427 and B.1.429, of the California variant can be found in about a quarter of the sequenced gene samples in California.

What do we know about the two American variants?

To date, we do not have complete reliable data on these variants. The California variant, CAL.20C, is said to be more contagious than the original SARS-CoV-2 virus. In swabs taken from infected individuals, the viral load in the samples was found to be somewhat doubled. But it is less infectious than the British mutant B.1.1.7, which has now been detected in a large number of countries, including Germany. Existing vaccines are considered to be somewhat less effective against the California virus variant, but still sufficient to protect patients from a severe course of COVID-19.

The New York virus variant, B.1.526, is similar to the South African variant, B.1.351, which has already been detected in over 40 countries and also has similarities to the Brazilian variants, P.1 and P.2, which have been detected in over 20 countries, most recently in the United Kingdom.

It is not yet clear whether the New York variant is more contagious or dangerous and whether existing vaccines are still sufficiently effective against this variant.

New software helps with search

Finding those options is only possible if you know what to look for. Although we now know the SARS-CoV-2 genome, the virus has a length of 29,903 nucleotides, which is far too long to make it possible to quickly identify variants that can make it more infectious among the 611,000 genomes now stored in the GISAID database. .

The mutations were found using new software called the Variant Database (VDB) developed at the California Institute of Technology in Pasadena by a team led by Pamela Bjorkman. Focuses on spike protein changes.

A man receives a buffer test in Johannesburg

A mutation called E484K was found in both the South African and Brazilian versions.

The potentially dangerous E484K mutation, which is present in B.1.351 and P.1, alters the binding domain of spike protein receptors, and here it attacks antibodies with the strongest neutralizing effect.

A cause for concern, but not panic

The tip of the spike protein is also modified in the New York variant. Understandably, this has caused some concern, Columbia University epidemiologist Wafaa El-Sadr told German public broadcaster ARD. These changes can lead to spike protein that can attach better. Or that the virus can reproduce faster. Or that antibodies can’t be fought with our vaccines, he said.

But until detailed and robust data on US variants are available, these remarks remain speculative and there is no need to panic, said Dave Chokshi, commissioner at the New York Department of Mental Health and Hygiene. So far, there is no evidence that it is spreading faster, whether it makes people sick or reduces the effectiveness of the vaccine, he said.

This article was translated from German.

.Source